PSMAddition: A phase 3 trial to compare treatment with 177Lu-PSMA-617 plus SOC versus SOC alone in patients with metastatic HSPC Meeting Abstract


Authors: Berthold, D.; Tagawa, S.; Sartor, O.; Parker, C.; Saad, F.; Sakharova, O.; de Bono, J.; Feng, F.; Fizazi, K.; Morris, M.
Abstract Title: PSMAddition: A phase 3 trial to compare treatment with 177Lu-PSMA-617 plus SOC versus SOC alone in patients with metastatic HSPC
Meeting Title: 5th Swiss Oncology and Hematology Congress (SOHC)
Journal Title: Swiss Medical Weekly
Volume: 152
Issue: Suppl. 265
Meeting Dates: 2022 Nov 16-18
Meeting Location: Basel, Switzerland
ISSN: 1424-7860
Publisher: E M H Swiss Medical Publishers Ltd  
Date Published: 2022-11-14
Start Page: 66S
Language: English
ACCESSION: WOS:000912385900112
PROVIDER: wos
DOI: 10.57187/smw.2022.40034
Notes: Meeting Abstract: 51 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Morris
    577 Morris